These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2923583)
1. Contraceptive steroid effects on lipids and lipoproteins in cynomolgus monkeys. Parks JS; Pelkey SJ; Babiak J; Clarkson TB Arteriosclerosis; 1989; 9(2):261-8. PubMed ID: 2923583 [TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
3. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study. Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633 [TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives, lipoproteins, and atherosclerosis. Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963 [TBL] [Abstract][Full Text] [Related]
5. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262 [TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M; Almström E; Högstedt S; Nabrink M Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
8. Effects of oral contraceptives on lipoprotein lipids: a prospective study. Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714 [TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
10. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
11. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
12. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Oyelola OO Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671 [TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Clarkson TB; Shively CA; Morgan TM; Koritnik DR; Adams MR; Kaplan JR Obstet Gynecol; 1990 Feb; 75(2):217-22. PubMed ID: 2300348 [TBL] [Abstract][Full Text] [Related]
14. A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism. Kakis G; Powell M; Marshall A; Steiner G Contraception; 1993 Feb; 47(2):131-48. PubMed ID: 8449014 [TBL] [Abstract][Full Text] [Related]
15. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Larsson-Cohn U; Wallentin L; Zador G Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252 [TBL] [Abstract][Full Text] [Related]
16. The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women. Percival-Smith RK; Morrison BJ; Sizto R; Abercrombie B Contraception; 1987 Feb; 35(2):179-87. PubMed ID: 3595143 [TBL] [Abstract][Full Text] [Related]
17. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women. Prasad RN; Liew D; Ratnam SS Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321 [TBL] [Abstract][Full Text] [Related]
18. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism. Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546 [TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen. Nash AL; Cornish EJ; Hain R Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]